CT regimen: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen consisting of [[Cisplatin]], [[Paclitaxel|paclitaxel (Taxol)]] used to treat advanced epithelial ovarian cancer.<ref name="pmid16394300">{{cite journal| author=Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S et al.| title=Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | journal=N Engl J Med | year= 2006 | volume= 354 | issue= 1 | pages= 34-43 | pmid=16394300 | doi=10.1056/NEJMoa052985 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16394300 }} </ref> | {{PAGENAME}} refers to a regimen consisting of [[Cisplatin]], [[Paclitaxel|paclitaxel (Taxol)]] used to treat [[ovarian cancer|advanced epithelial ovarian cancer]].<ref name="pmid16394300">{{cite journal| author=Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S et al.| title=Intraperitoneal cisplatin and paclitaxel in ovarian cancer. | journal=N Engl J Med | year= 2006 | volume= 354 | issue= 1 | pages= 34-43 | pmid=16394300 | doi=10.1056/NEJMoa052985 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16394300 }} </ref> | ||
==Regimen== | ==Regimen== |
Latest revision as of 13:40, 12 March 2015
WikiDoc Resources for CT regimen |
Articles |
---|
Most recent articles on CT regimen |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on CT regimen at Clinical Trials.gov Clinical Trials on CT regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on CT regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on CT regimen Discussion groups on CT regimen Patient Handouts on CT regimen Directions to Hospitals Treating CT regimen Risk calculators and risk factors for CT regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for CT regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:
Overview
CT regimen refers to a regimen consisting of Cisplatin, paclitaxel (Taxol) used to treat advanced epithelial ovarian cancer.[1]
Regimen
CCisplatin
TPaclitaxel (Taxol)
Indications
References
- ↑ 1.0 1.1 Armstrong DK, Bundy B, Wenzel L, Huang HQ, Baergen R, Lele S; et al. (2006). "Intraperitoneal cisplatin and paclitaxel in ovarian cancer". N Engl J Med. 354 (1): 34–43. doi:10.1056/NEJMoa052985. PMID 16394300.